Your browser doesn't support javascript.
loading
Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus.
Orlova, O V; Glazkova, D V; Tsyganova, G M; Antoshkina, I V; Mintaev, R R; Tikhonov, A S; Bogoslovskaya, E V; Shipulin, G A.
Afiliação
  • Orlova OV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia. Electronic address: orlovaov@gmail.com.
  • Glazkova DV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia.
  • Tsyganova GM; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia.
  • Antoshkina IV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia.
  • Mintaev RR; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia; I. Mechnikov Research Institute of Vaccines and Sera, 105064, Moscow, Russia.
  • Tikhonov AS; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia.
  • Bogoslovskaya EV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia.
  • Shipulin GA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks¼ of the Federal Medical Biological Agency", 119121, Moscow, Russia.
J Virol Methods ; 289: 114056, 2021 03.
Article em En | MEDLINE | ID: mdl-33359615

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vaccinia virus / Vetores Genéticos / SARS-CoV-2 / Antígenos Virais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vaccinia virus / Vetores Genéticos / SARS-CoV-2 / Antígenos Virais Idioma: En Ano de publicação: 2021 Tipo de documento: Article